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area correlated well with human measurements, and can be used in
the future for volumetric assessments of the ﬁbrous cap with a high
degree of accuracy.
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BACKGROUND Culprit lesions in myocardial infarction frequently harbor
a lipid burden exceeding a maximum lipid-core burden index in 4-mm
(maxLCBI4mm) of 400, as deﬁned by intracoronary near-infrared spec-
troscopy (NIRS). Whether non-culprit atheroma with a plaque
burden 70% (PB70), the intravascular ultrasound (IVUS) characteristic
most strongly associated with future lesion-speciﬁc events, concurrently
harbor a maxLCBI4mm 400 remains unknown. Using hybrid NIRS-IVUS
imaging, the present analysis was undertaken to: 1) evaluate the correla-
tion between PB measured by IVUS and lipid burden measured by NIRS in
vivo; and 2) determine the prevalence of non-culprit PB70 lesions that
have a maxLCBI4mm 400 among non-culprit coronary atheroma.
METHODS Among consecutive patients undergoing NIRS-IVUS imag-
ing as part of a single center registry, non-culprit portions of the target
arteries were divided into contiguous 10-mm non-culprit segments.
PB in all segments was assessed by quantitative IVUS. Only lesions
having a PB 40% were included in the present analysis. NIRS-
derived lipid burden in all lesions was measured as maxLCBI4mm.
Summary statistics were used to describe the relationship between PB
and maxLCBI4mm within non-culprit lesions.
RESULTS In 121 patients, 292 non-culprit lesions (mean PB 56  10%)
were identiﬁed. A signiﬁcant but modest positive correlation was
found between PB and maxLCBI4mm (R¼0.32, 95% CI 0.22-0.42,
p<0.001, Figure). Although PB70 lesions had a greater maxLCBI4mm
than non-PB70 lesions (186 [51, 267] vs. 50 [0, 181], p ¼ 0.02), only
17.1% of PB70 lesions contained a maxLCBI4mm 400. PB70 lesions
having a maxLCBI4mm 400 were rare overall, accounting for only
2.1% of all non-culprit plaques.CONCLUSIONS We found a signiﬁcant yet modest positive correlation
between PB and lipid burden within non-culprit plaques. PB70 lesions
harboring a maxLCBI4mm 400 are proportionately rare and
accounted for only 2% of all non-culprit plaques. Whether these rare
lesions having the IVUS feature most predictive of site-speciﬁc future
events, coupled with a NIRS lipid burden characteristic of culprit le-
sions in myocardial infarction, will ultimately associate with future
acute coronary events remains unknown.
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BACKGROUND Color intensity and neointimal coverage after drug-
eluting stent (DES) evaluated by coronary angioscopy (CAS)maypredict
late stent failure and stent thrombosis. However, the histopathological
comparison data is limited. We evaluated the histological characteris-
tics of DES characterized by CAS in coronary autopsy specimens.
METHODS A total of 14 DESs were examined to compare CAS and
histological images. CAS examination was performed based on tissue
structure and color intensity classiﬁed either white or yellow. Stent
coverage was graded as 0, stent struts exposed; grade 1, struts bulging
into the lumen, but still transparently visible although covered; grade
2, struts embedded in the neointima, but translucent; grade 3, struts
fully embedded and invisible. Each examination was performed at
each 3-mm interval of the entire DES.
RESULTS Sixty-one segments were matched to CAS and histological
analysis. Of these, 37 were categorized as white and 24 were yellow on
CAS. Histological analysis revealed white segments was entirely
comprised of smooth muscle cells with an extracellular matrix containing
collagens, indicating high neointimal maturity. On the other hand, seg-
ments classiﬁed as yellow contained ﬁbroatheroma (n¼3), foam cells
accumulation (n¼12) or superﬁcial calcium deposition (n¼9) (Figure).
Intimal coverage grade was well correlated with histological neointimal
thickness (grade 0 [n ¼ 21] 109 mm, grade 1 [n ¼20] 11570 mm, grade 2
[n ¼12] 487 243 mm, and grade 3 [n ¼9] 969 404 mm; p<0.05).
CONCLUSIONS In-stent yellow intima includes various types of
atherosclerotic components, such as ﬁbroatheroma formation, foam
cell accumulation and superﬁcial calcium deposition. CAS has the
capability to evaluate vascular response of DES accurately.
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